INC Research CEO reflects on Kendle acquisition

By Gareth Macdonald

- Last updated on GMT

Related tags: Pharmacology

INC Research CEO reflects on Kendle acquisition
INC Research CEO James Ogle tells Outsourcing-pharma.com that the acquisition of fellow CRO Kendle was about building a presence in emerging trial hotspots and pharmaceutical markets.

The $232m (€165m) acquisition of Kendle earlier​ this month gives INC a presence in Latin America and Asia, broadens its therapeutic reach and provides an expanded customer base according to Ogle.

The key thing here is we are looking at ‘Where is drug development going?’ And, I think the most important thing is that our customers are looking at developing drugs in areas where the ultimately hope to sell them​.”

Ogle also set out INC’s integrations strategy, explaining that the policy is to look for the best person for a particular role “regardless of what legacy part of the business they come from​.”

He also spoke about the firm’s track record of acquisitions – MDS Pharma Services late-stage unit and Trident – and said that while no further takeovers are planned if the correct opportunity arises INC will consider further deals.

Related news

Show more

Related products

show more

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 16-Jan-2023 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Optimizing Adherence in DCTs

Optimizing Adherence in DCTs

PPD - Decentralized Clinical Trials | 12-Jan-2023 | Technical / White Paper

Prioritizing greater patient-centricity and creating an opportunity to reach unprecedented patient groups, decentralized and hybrid clinical trials are...

PPD is Supporting Complex EU DCTs

PPD is Supporting Complex EU DCTs

PPD - Decentralized Clinical Trials | 05-Jan-2023 | Technical / White Paper

PPD supports European DCTs and clinical trial sponsors with a holistic and comprehensive approach

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 14-Dec-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars